Volition, Standard Capital deal

Diagnostic company Volition will reverse-merge with Standard Capital in a stock deal. Volition shareholders will exchange 6.9 million shares for Standard Capital shares at a 1-for-1 ratio. Volition will become VolitionRx Ltd. and trade on the OTC Bulletin Board under the ticker "VOLN." The combined company will develop Volition's blood-based cancer diagnostics. The reverse merger is subject to Volition shareholder approval and is expected to close Oct. 6. Details were not disclosed. ...